“I wonder how much money is going under the table to various bigwigs in government to keep the mRNA vaccine gravy train running full speed ahead.” Admin
The vaccine rollout has been a bonanza for drug manufacturers, making the production of COVID-19 vaccines one of the most lucrative businesses these days.
Reportedly, Moderna’s share price has gained more than 700 percent since February 2020. Pfizer stock price has surged nearly 50 percent since last year, while its German partner, BioNTech, went from a startup to a multibillion-dollar company in just months, whose share price grew by 600 percent. Chinese CanSino Biologics’ stock is up about 440 percent over the same period.
The COVID-19 vaccine industry has added nine names to the Forbes Rich list.
Topping the list of new billionaires are Moderna CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer. Both CEOs are now worth around $4 billion, according to an analysis by the People’s Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now, and Amnesty International.
Read More: COVID-19 Vaccine Manufacturers Make a Fortune, Produce Nine New Billionaires – The New American
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr